Recruiting
Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma
NCT07780838
- Conditions
- Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +33 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States